Giving Surgeons a (Mechanical) Hand
This article was originally published in Start Up
Big companies are taking start-ups in the surgical robotics field seriously.
You may also be interested in...
Tired of fighting each other in court, the two leading robotics companies have decided to render their IP differences moot through a merger.
The latest accelerated approval withdrawals in the US are milestones for accountability in the program – most notably with the withdrawal of an antimicrobial with confirmatory studies more than a decade overdue.
Based on promising Phase II data, two companies in South Korea are moving ahead with late-stage development in the gout space, with JW Pharmaceutical getting approvals to begin a multinational Phase III trial for epaminurad, while LG Chem has recently submitted an application for a Phase III program with its contender tigulixostat.